Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384200138> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4384200138 abstract "<div>Abstract<p>While the role of prostaglandin E2 (PGE2) in promoting malignant progression is well-established, how to optimally block the activity of PGE2 signaling remains to be demonstrated. Clinical trials with prostaglandin pathway targeted agents have shown activity but without sufficient significance or dose-limiting toxicities that have prevented approval. PGE2 signals through four receptors (EP1-4) to modulate tumor progression. EP2 and EP4 signaling exacerbates tumor pathology and is immunosuppressive through potentiating cAMP production. EP1 and EP3 signaling has the opposite effect through increasing IP3 and decreasing cAMP. Using available single small molecule antagonists of EP receptors, the COX-2 inhibitor celecoxib and a dual EP2/EP4 antagonist generated in this investigation, we tested which approach to block PGE2 signaling optimally restored immunologic activity in mouse and human immune cells and antitumor activity in syngeneic, spontaneous and xenograft tumor models. We found that dual antagonism of EP2 and EP4 together significantly enhanced the activation of PGE2-suppressed mouse and human monocytes and CD8+ T cells in vitro as compared to single EP antagonists. CD8+ T cell activation was dampened by single EP1 and EP3 antagonists. Dual EP2/EP4 PGE2 receptor antagonists increased TME lymphocyte infiltration and significantly reduced disease burden in multiple tumor models, including in the adenomatous polyposis coli (APC)min+/- spontaneous colorectal tumor model, compared to celecoxib. These results support a hypothesis that redundancy of EP2 and EP4 receptor signaling necessitates a therapeutic strategy of dual blockade of EP2 and EP4. Here we describe TPST-1495, a first-in-class orally available small molecule dual EP2/EP4 antagonist.</p></div>" @default.
- W4384200138 created "2023-07-14" @default.
- W4384200138 creator A5014835615 @default.
- W4384200138 creator A5020753736 @default.
- W4384200138 creator A5031059803 @default.
- W4384200138 creator A5043190036 @default.
- W4384200138 creator A5046915476 @default.
- W4384200138 creator A5050774369 @default.
- W4384200138 creator A5060816751 @default.
- W4384200138 creator A5065516958 @default.
- W4384200138 creator A5070910059 @default.
- W4384200138 creator A5075631226 @default.
- W4384200138 creator A5079648908 @default.
- W4384200138 creator A5080671438 @default.
- W4384200138 creator A5090373031 @default.
- W4384200138 date "2023-07-13" @default.
- W4384200138 modified "2023-09-23" @default.
- W4384200138 title "Data from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Anti-Tumor Activity Against Prostaglandin-Expressing Tumors" @default.
- W4384200138 doi "https://doi.org/10.1158/2767-9764.c.6740592.v1" @default.
- W4384200138 hasPublicationYear "2023" @default.
- W4384200138 type Work @default.
- W4384200138 citedByCount "0" @default.
- W4384200138 crossrefType "posted-content" @default.
- W4384200138 hasAuthorship W4384200138A5014835615 @default.
- W4384200138 hasAuthorship W4384200138A5020753736 @default.
- W4384200138 hasAuthorship W4384200138A5031059803 @default.
- W4384200138 hasAuthorship W4384200138A5043190036 @default.
- W4384200138 hasAuthorship W4384200138A5046915476 @default.
- W4384200138 hasAuthorship W4384200138A5050774369 @default.
- W4384200138 hasAuthorship W4384200138A5060816751 @default.
- W4384200138 hasAuthorship W4384200138A5065516958 @default.
- W4384200138 hasAuthorship W4384200138A5070910059 @default.
- W4384200138 hasAuthorship W4384200138A5075631226 @default.
- W4384200138 hasAuthorship W4384200138A5079648908 @default.
- W4384200138 hasAuthorship W4384200138A5080671438 @default.
- W4384200138 hasAuthorship W4384200138A5090373031 @default.
- W4384200138 hasBestOaLocation W43842001382 @default.
- W4384200138 hasConcept C126322002 @default.
- W4384200138 hasConcept C167672396 @default.
- W4384200138 hasConcept C170493617 @default.
- W4384200138 hasConcept C178592051 @default.
- W4384200138 hasConcept C203014093 @default.
- W4384200138 hasConcept C2777198256 @default.
- W4384200138 hasConcept C2777956040 @default.
- W4384200138 hasConcept C2778938600 @default.
- W4384200138 hasConcept C2780664492 @default.
- W4384200138 hasConcept C502942594 @default.
- W4384200138 hasConcept C62478195 @default.
- W4384200138 hasConcept C71924100 @default.
- W4384200138 hasConcept C86803240 @default.
- W4384200138 hasConcept C8891405 @default.
- W4384200138 hasConcept C95444343 @default.
- W4384200138 hasConcept C98274493 @default.
- W4384200138 hasConceptScore W4384200138C126322002 @default.
- W4384200138 hasConceptScore W4384200138C167672396 @default.
- W4384200138 hasConceptScore W4384200138C170493617 @default.
- W4384200138 hasConceptScore W4384200138C178592051 @default.
- W4384200138 hasConceptScore W4384200138C203014093 @default.
- W4384200138 hasConceptScore W4384200138C2777198256 @default.
- W4384200138 hasConceptScore W4384200138C2777956040 @default.
- W4384200138 hasConceptScore W4384200138C2778938600 @default.
- W4384200138 hasConceptScore W4384200138C2780664492 @default.
- W4384200138 hasConceptScore W4384200138C502942594 @default.
- W4384200138 hasConceptScore W4384200138C62478195 @default.
- W4384200138 hasConceptScore W4384200138C71924100 @default.
- W4384200138 hasConceptScore W4384200138C86803240 @default.
- W4384200138 hasConceptScore W4384200138C8891405 @default.
- W4384200138 hasConceptScore W4384200138C95444343 @default.
- W4384200138 hasConceptScore W4384200138C98274493 @default.
- W4384200138 hasLocation W43842001381 @default.
- W4384200138 hasLocation W43842001382 @default.
- W4384200138 hasOpenAccess W4384200138 @default.
- W4384200138 hasPrimaryLocation W43842001381 @default.
- W4384200138 hasRelatedWork W1973692206 @default.
- W4384200138 hasRelatedWork W2009676263 @default.
- W4384200138 hasRelatedWork W2018440490 @default.
- W4384200138 hasRelatedWork W2029972069 @default.
- W4384200138 hasRelatedWork W2076243961 @default.
- W4384200138 hasRelatedWork W2093688021 @default.
- W4384200138 hasRelatedWork W2125973204 @default.
- W4384200138 hasRelatedWork W2339856804 @default.
- W4384200138 hasRelatedWork W2386527038 @default.
- W4384200138 hasRelatedWork W2416082857 @default.
- W4384200138 isParatext "false" @default.
- W4384200138 isRetracted "false" @default.
- W4384200138 workType "article" @default.